The University of Chicago Header Logo

Connection

Mark K. Ferguson to Middle Aged

Back to Details
This is a "connection" page, showing publications Mark K. Ferguson has written about Middle Aged.
Mark K. Ferguson
Connection Strength
1.158
Middle Aged
  1. Outpatient Thoracoscopic Mediastinal Biopsy: A Safe and Cost-Effective Approach. Ann Thorac Surg. 2020 11; 110(5):1726-1729.
    View in: PubMed
    Score: 0.049
  2. Gender Bias Affects Assessment of Frailty and Recommendations for Surgery. Ann Thorac Surg. 2020 03; 109(3):938-944.
    View in: PubMed
    Score: 0.047
  3. Do Estimates of Treatment Risk Based on Clinical Vignettes Differ by Physician Gender? Ann Thorac Surg. 2018 12; 106(6):1868-1872.
    View in: PubMed
    Score: 0.044
  4. Does Race Influence Risk Assessment and Recommendations for Lung Resection? A Randomized Trial. Ann Thorac Surg. 2018 10; 106(4):1013-1017.
    View in: PubMed
    Score: 0.043
  5. The Influence of Physician and Patient Gender on Risk Assessment for Lung Cancer Resection. Ann Thorac Surg. 2017 Jul; 104(1):284-289.
    View in: PubMed
    Score: 0.040
  6. Screening for Frailty in Thoracic Surgical Patients. Ann Thorac Surg. 2017 Mar; 103(3):956-961.
    View in: PubMed
    Score: 0.038
  7. Spontaneous esophageal perforation (Boerhaave syndrome) successfully treated with an over-the-scope clip and fully covered metal stent. Gastrointest Endosc. 2016 Mar; 83(3):650.
    View in: PubMed
    Score: 0.036
  8. Lung function predicts pulmonary complications regardless of the surgical approach. Ann Thorac Surg. 2015 May; 99(5):1761-7.
    View in: PubMed
    Score: 0.034
  9. The impact of perceived frailty on surgeons' estimates of surgical risk. Ann Thorac Surg. 2014 Jul; 98(1):210-6.
    View in: PubMed
    Score: 0.033
  10. Prediction of major cardiovascular events after lung resection using a modified scoring system. Ann Thorac Surg. 2014 Apr; 97(4):1135-40.
    View in: PubMed
    Score: 0.032
  11. Association of body mass index and outcomes after major lung resection. Eur J Cardiothorac Surg. 2014 Apr; 45(4):e94-9; discussion e99.
    View in: PubMed
    Score: 0.032
  12. Competence versus mastery: the time course for developing proficiency in video-assisted thoracoscopic lobectomy. J Thorac Cardiovasc Surg. 2014 Apr; 147(4):1150-4.
    View in: PubMed
    Score: 0.032
  13. Predicted postoperative lung function is associated with all-cause long-term mortality after major lung resection for cancer. Eur J Cardiothorac Surg. 2014 Apr; 45(4):660-4.
    View in: PubMed
    Score: 0.031
  14. Can we predict morbidity and mortality before an operation? Thorac Surg Clin. 2013 Aug; 23(3):287-99.
    View in: PubMed
    Score: 0.030
  15. Validation of a modified scoring system for cardiovascular risk associated with major lung resection. Eur J Cardiothorac Surg. 2012 Mar; 41(3):598-602.
    View in: PubMed
    Score: 0.027
  16. Assessment of a scoring system for predicting complications after esophagectomy. Dis Esophagus. 2011 Sep; 24(7):510-5.
    View in: PubMed
    Score: 0.026
  17. Thoracic surgery in the elderly. Foreword. Thorac Surg Clin. 2009 Aug; 19(3):ix-x.
    View in: PubMed
    Score: 0.023
  18. Quality of life and mood in older patients after major lung resection. Ann Thorac Surg. 2009 Apr; 87(4):1007-12; discussion 1012-3.
    View in: PubMed
    Score: 0.023
  19. Modeling major lung resection outcomes using classification trees and multiple imputation techniques. Eur J Cardiothorac Surg. 2008 Nov; 34(5):1085-9.
    View in: PubMed
    Score: 0.022
  20. Diffusing capacity predicts morbidity after lung resection in patients without obstructive lung disease. Ann Thorac Surg. 2008 Apr; 85(4):1158-64; discussion 1164-5.
    View in: PubMed
    Score: 0.021
  21. Bowel necrosis associated with early jejunal tube feeding: A complication of postoperative enteral nutrition. Arch Surg. 2006 Jul; 141(7):701-4.
    View in: PubMed
    Score: 0.019
  22. Induction therapy does not increase surgical morbidity after esophagectomy for cancer. Ann Thorac Surg. 2004 Nov; 78(5):1783-9.
    View in: PubMed
    Score: 0.017
  23. Germline Variants Incidentally Detected via Tumor-Only Genomic Profiling of Patients With Mesothelioma. JAMA Netw Open. 2023 08 01; 6(8):e2327351.
    View in: PubMed
    Score: 0.015
  24. Postpneumonectomy pulmonary edema. J Cardiothorac Vasc Anesth. 2003 Jun; 17(3):388-95.
    View in: PubMed
    Score: 0.015
  25. A comparison of three scoring systems for predicting complications after major lung resection. Eur J Cardiothorac Surg. 2003 Jan; 23(1):35-42.
    View in: PubMed
    Score: 0.015
  26. Preoperative prediction of the risk of pulmonary complications after esophagectomy for cancer. J Thorac Cardiovasc Surg. 2002 Apr; 123(4):661-9.
    View in: PubMed
    Score: 0.014
  27. Long-term survival after esophagectomy for Barrett's adenocarcinoma in endoscopically surveyed and nonsurveyed patients. J Gastrointest Surg. 2002 Jan-Feb; 6(1):29-35; discussion 36.
    View in: PubMed
    Score: 0.014
  28. CDKN2A loss-of-function predicts immunotherapy resistance in non-small cell lung cancer. Sci Rep. 2021 10 08; 11(1):20059.
    View in: PubMed
    Score: 0.014
  29. Risk Prediction Model of 90-Day Mortality After Esophagectomy for Cancer. JAMA Surg. 2021 09 01; 156(9):836-845.
    View in: PubMed
    Score: 0.013
  30. U.S. trends in elective and emergent major abdominal surgical procedures from 2002 to 2014 in older adults. J Am Geriatr Soc. 2021 08; 69(8):2220-2230.
    View in: PubMed
    Score: 0.013
  31. Clinical predictors of donor antibody titre and correlation with recipient antibody response in a COVID-19 convalescent plasma clinical trial. J Intern Med. 2021 04; 289(4):559-573.
    View in: PubMed
    Score: 0.013
  32. Long-term outcome after resection for bronchial carcinoid tumors. Eur J Cardiothorac Surg. 2000 Aug; 18(2):156-61.
    View in: PubMed
    Score: 0.012
  33. Does pneumonectomy for lung cancer adversely influence long-term survival? J Thorac Cardiovasc Surg. 2000 Mar; 119(3):440-8.
    View in: PubMed
    Score: 0.012
  34. Evaluation of the Association of Perioperative UGT1A1 Genotype-Dosed gFOLFIRINOX With Margin-Negative Resection Rates and Pathologic Response Grades Among Patients With Locally Advanced Gastroesophageal Adenocarcinoma: A Phase 2 Clinical Trial. JAMA Netw Open. 2020 02 05; 3(2):e1921290.
    View in: PubMed
    Score: 0.012
  35. Sex-associated differences in survival of patients undergoing resection for lung cancer. Ann Thorac Surg. 2000 Jan; 69(1):245-9; discussion 249-50.
    View in: PubMed
    Score: 0.012
  36. Diffusing capacity predicts operative mortality but not long-term survival after resection for lung cancer. J Thorac Cardiovasc Surg. 1999 Mar; 117(3):581-6; discussion 586-7.
    View in: PubMed
    Score: 0.011
  37. Resection for Barrett's mucosa with high-grade dysplasia: implications for prophylactic photodynamic therapy. J Thorac Cardiovasc Surg. 1997 Nov; 114(5):824-9.
    View in: PubMed
    Score: 0.010
  38. Effect of Endoscopic Bronchial Ultrasound on Outcomes for Stage I Non-Small-Cell Lung Cancer Patients Receiving Hypofractionated Radiotherapy. Clin Lung Cancer. 2018 03; 19(2):e227-e233.
    View in: PubMed
    Score: 0.010
  39. Coronary artery disease is associated with an increased mortality rate following video-assisted thoracoscopic lobectomy. J Thorac Cardiovasc Surg. 2017 07; 154(1):352-357.
    View in: PubMed
    Score: 0.010
  40. Risk-stratifying capacity of PET/CT metabolic tumor volume in stage IIIA non-small cell lung cancer. Eur J Nucl Med Mol Imaging. 2017 Aug; 44(8):1275-1284.
    View in: PubMed
    Score: 0.010
  41. Prognostic value of quantitative PET/CT in patients with a nonsmall cell lung cancer and another primary cancer. Nucl Med Commun. 2017 Feb; 38(2):185-192.
    View in: PubMed
    Score: 0.010
  42. Outcome after failed initial therapy for rupture of the esophagus or intrathoracic stomach. J Gastrointest Surg. 1997 Jan-Feb; 1(1):34-9.
    View in: PubMed
    Score: 0.010
  43. Use of pleural catheter for the management of simple pneumothorax. Chest. 1996 Nov; 110(5):1169-72.
    View in: PubMed
    Score: 0.010
  44. Results of myotomy and partial fundoplication after pneumatic dilation for achalasia. Ann Thorac Surg. 1996 Aug; 62(2):327-30.
    View in: PubMed
    Score: 0.009
  45. Limitations of PET/CT in the Detection of Occult N1 Metastasis in Clinical Stage I(T1-2aN0) Non-Small Cell Lung Cancer for Staging Prior to Stereotactic Body Radiotherapy. Technol Cancer Res Treat. 2017 02; 16(1):15-21.
    View in: PubMed
    Score: 0.009
  46. Comprehensive genetic testing identifies targetable genomic alterations in most patients with non-small cell lung cancer, specifically adenocarcinoma, single institute investigation. Oncotarget. 2016 Apr 05; 7(14):18876-86.
    View in: PubMed
    Score: 0.009
  47. Doubling of 30-Day Mortality by 90 Days After Esophagectomy: A Critical Measure of Outcomes for Quality Improvement. Ann Surg. 2016 Feb; 263(2):286-91.
    View in: PubMed
    Score: 0.009
  48. Current results of therapy for esophageal perforation. Am J Surg. 1995 Jun; 169(6):615-7.
    View in: PubMed
    Score: 0.009
  49. Intensive multimodality therapy for carcinoma of the esophagus and gastroesophageal junction. Ann Surg Oncol. 1995 Mar; 2(2):101-6.
    View in: PubMed
    Score: 0.009
  50. External validation of the Ferguson pulmonary risk score for predicting major pulmonary complications after oesophagectomy†. Eur J Cardiothorac Surg. 2016 Jan; 49(1):333-8.
    View in: PubMed
    Score: 0.009
  51. Optimizing selection of patients for major lung resection. J Thorac Cardiovasc Surg. 1995 Feb; 109(2):275-81; discussion 281-3.
    View in: PubMed
    Score: 0.009
  52. How accurate are anatomic landmarks for femoral tunnel positioning in anterior cruciate ligament reconstruction? An in vivo imaging analysis comparing both anteromedial portal and outside-in techniques. Arthroscopy. 2015 May; 31(5):882-9.
    View in: PubMed
    Score: 0.009
  53. Transcervical thymectomy for myasthenia gravis. Ann Thorac Surg. 1994 Jan; 57(1):194-7.
    View in: PubMed
    Score: 0.008
  54. Improved survival associated with neoadjuvant chemoradiation in patients with clinical stage IIIA(N2) non-small-cell lung cancer. J Thorac Oncol. 2013 Jul; 8(7):915-22.
    View in: PubMed
    Score: 0.008
  55. Pathologic response rates following definitive dose image-guided chemoradiotherapy and resection for locally advanced non-small cell lung cancer. Lung Cancer. 2011 Dec; 74(3):446-50.
    View in: PubMed
    Score: 0.007
  56. MET and phosphorylated MET as potential biomarkers in lung cancer. J Environ Pathol Toxicol Oncol. 2011; 30(4):341-54.
    View in: PubMed
    Score: 0.006
  57. Predicting failure following shunting of pleural effusions. Chest. 1990 Oct; 98(4):890-3.
    View in: PubMed
    Score: 0.006
  58. Long-term outcome of a phase II study of docetaxel-based multimodality chemoradiotherapy for locally advanced carcinoma of the esophagus or gastroesophageal junction. Med Oncol. 2011 Dec; 28 Suppl 1:S152-61.
    View in: PubMed
    Score: 0.006
  59. Sex-associated differences in presentation and survival in patients with lung cancer. J Clin Oncol. 1990 Aug; 8(8):1402-7.
    View in: PubMed
    Score: 0.006
  60. Does induction treatment increase the risk of morbidity and mortality after pneumonectomy? A multicentre case-matched analysis. Eur J Cardiothorac Surg. 2010 Mar; 37(3):535-9.
    View in: PubMed
    Score: 0.006
  61. Ethnic differences and functional analysis of MET mutations in lung cancer. Clin Cancer Res. 2009 Sep 15; 15(18):5714-23.
    View in: PubMed
    Score: 0.006
  62. Early evaluation and therapy for caustic esophageal injury. Am J Surg. 1989 Jan; 157(1):116-20.
    View in: PubMed
    Score: 0.006
  63. Lymphatic vessel density is not associated with lymph node metastasis in non-small cell lung carcinoma. Arch Pathol Lab Med. 2008 Dec; 132(12):1882-8.
    View in: PubMed
    Score: 0.006
  64. Diffusing capacity predicts morbidity and mortality after pulmonary resection. J Thorac Cardiovasc Surg. 1988 Dec; 96(6):894-900.
    View in: PubMed
    Score: 0.006
  65. A scoring system predicting the risk for intensive care unit admission for complications after major lung resection: a multicenter analysis. Ann Thorac Surg. 2008 Jul; 86(1):213-8.
    View in: PubMed
    Score: 0.005
  66. Phase I study of induction chemotherapy and concomitant chemoradiotherapy with irinotecan, carboplatin, and paclitaxel for stage III non-small cell lung cancer. J Thorac Oncol. 2008 Jan; 3(1):59-67.
    View in: PubMed
    Score: 0.005
  67. Selective operative approach for diagnosis and treatment of anterior mediastinal masses. Ann Thorac Surg. 1987 Dec; 44(6):583-6.
    View in: PubMed
    Score: 0.005
  68. Chemotherapy and high dose radiotherapy followed by resection for locally advanced nonsmall cell lung cancers. Am J Clin Oncol. 2007 Jun; 30(3):258-63.
    View in: PubMed
    Score: 0.005
  69. Phase I study of vinorelbine, cisplatin, and concomitant thoracic radiation in the treatment of advanced chest malignancies. J Clin Oncol. 1998 Jun; 16(6):2157-63.
    View in: PubMed
    Score: 0.003
  70. Induction chemotherapy, surgery, and concomitant chemoradiotherapy for carcinoma of the esophagus: a long-term analysis. Ann Oncol. 1998 Jun; 9(6):647-51.
    View in: PubMed
    Score: 0.003
  71. Management of giant paraesophageal hernia. Dis Esophagus. 1997 Jan; 10(1):47-50.
    View in: PubMed
    Score: 0.002
  72. Vinorelbine (Navelbine), cisplatin, and concomitant radiation therapy for advanced malignancies of the chest: a Phase I study. Semin Oncol. 1996 Apr; 23(2 Suppl 5):48-52.
    View in: PubMed
    Score: 0.002
  73. A phase I trial of concomitant chemoradiotherapy with cisplatin dose intensification and granulocyte-colony stimulating factor support for advanced malignancies of the chest. Cancer Chemother Pharmacol. 1995; 35(4):304-12.
    View in: PubMed
    Score: 0.002
  74. The impact on survival by adjuvant chemotherapy and radiation therapy in stage II non-small-cell lung cancer. Am J Clin Oncol. 1992 Oct; 15(5):405-11.
    View in: PubMed
    Score: 0.002
  75. Pericardial window: mechanisms of efficacy. Ann Thorac Surg. 1990 Sep; 50(3):442-5.
    View in: PubMed
    Score: 0.002
  76. 5-Fluorouracil with oral leucovorin and hydroxyurea and concomitant radiotherapy for stage III non-small cell lung cancer. Cancer. 1990 Aug 01; 66(3):437-42.
    View in: PubMed
    Score: 0.002
  77. Efficacy of computed tomography of the thorax and upper abdomen and whole-body gallium scintigraphy for staging of lung cancer. Cancer. 1989 Oct 01; 64(7):1404-8.
    View in: PubMed
    Score: 0.001
  78. Neoadjuvant vindesine, etoposide, and cisplatin for locally advanced non-small cell lung cancer. Final report of a phase 2 study. Chest. 1989 Jul; 96(1):110-3.
    View in: PubMed
    Score: 0.001
  79. Treatment of carcinoma of the proximal esophagus. Surg Gynecol Obstet. 1989 Apr; 168(4):307-10.
    View in: PubMed
    Score: 0.001
  80. Pleuro-peritoneal shunting. Alternative therapy for pleural effusions. Ann Surg. 1988 Oct; 208(4):443-50.
    View in: PubMed
    Score: 0.001
  81. Surgical management of esophageal strictures. Ann Thorac Surg. 1988 Feb; 45(2):144-7.
    View in: PubMed
    Score: 0.001
  82. Adenosquamous lung carcinoma: clinical characteristics, treatment, and prognosis. Ann Thorac Surg. 1987 Nov; 44(5):462-6.
    View in: PubMed
    Score: 0.001
  83. Colon interposition for benign esophageal disease. Surgery. 1987 Oct; 102(4):568-74.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.